These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
270 related items for PubMed ID: 18061195
1. Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. Wenzel P, Daiber A, Oelze M, Brandt M, Closs E, Xu J, Thum T, Bauersachs J, Ertl G, Zou MH, Förstermann U, Münzel T. Atherosclerosis; 2008 May; 198(1):65-76. PubMed ID: 18061195 [Abstract] [Full Text] [Related]
2. HMG-CoA reductase inhibitor increases GTP cyclohydrolase I mRNA and tetrahydrobiopterin in vascular endothelial cells. Hattori Y, Nakanishi N, Akimoto K, Yoshida M, Kasai K. Arterioscler Thromb Vasc Biol; 2003 Feb 01; 23(2):176-82. PubMed ID: 12588756 [Abstract] [Full Text] [Related]
3. Effects of atorvastatin, amlodipine, and their combination on vascular dysfunction in insulin-resistant rats. Okamura T, Tawa M, Geddawy A, Shimosato T, Iwasaki H, Shintaku H, Yoshida Y, Masada M, Shinozaki K, Imamura T. J Pharmacol Sci; 2014 Feb 01; 124(1):76-85. PubMed ID: 24389820 [Abstract] [Full Text] [Related]
4. Long-term atorvastatin improves age-related endothelial dysfunction by ameliorating oxidative stress and normalizing eNOS/iNOS imbalance in rat aorta. Gong X, Ma Y, Ruan Y, Fu G, Wu S. Exp Gerontol; 2014 Apr 01; 52():9-17. PubMed ID: 24463049 [Abstract] [Full Text] [Related]
6. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Wagner AH, Köhler T, Rückschloss U, Just I, Hecker M. Arterioscler Thromb Vasc Biol; 2000 Jan 01; 20(1):61-9. PubMed ID: 10634801 [Abstract] [Full Text] [Related]
7. Critical role for tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of endothelial nitric-oxide synthase coupling: relative importance of the de novo biopterin synthesis versus salvage pathways. Crabtree MJ, Tatham AL, Hale AB, Alp NJ, Channon KM. J Biol Chem; 2009 Oct 09; 284(41):28128-28136. PubMed ID: 19666465 [Abstract] [Full Text] [Related]
8. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F. Eur J Pharmacol; 2005 Mar 21; 511(1):53-64. PubMed ID: 15777779 [Abstract] [Full Text] [Related]
9. Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling. Antoniades C, Bakogiannis C, Leeson P, Guzik TJ, Zhang MH, Tousoulis D, Antonopoulos AS, Demosthenous M, Marinou K, Hale A, Paschalis A, Psarros C, Triantafyllou C, Bendall J, Casadei B, Stefanadis C, Channon KM. Circulation; 2011 Jul 19; 124(3):335-45. PubMed ID: 21730307 [Abstract] [Full Text] [Related]
10. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Mollnau H, Wendt M, Szöcs K, Lassègue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Förstermann U, Meinertz T, Griendling K, Münzel T. Circ Res; 2002 Mar 08; 90(4):E58-65. PubMed ID: 11884382 [Abstract] [Full Text] [Related]
13. Improved Endothelium-Dependent Relaxation of Thoracic Aorta in Niclosamide-Treated Diabetic Rats. Engin S, Yasar YK, Barut EN, Sezen SF. Cardiovasc Toxicol; 2021 Jul 23; 21(7):563-571. PubMed ID: 33772737 [Abstract] [Full Text] [Related]
14. Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo. Schäfer A, Alp NJ, Cai S, Lygate CA, Neubauer S, Eigenthaler M, Bauersachs J, Channon KM. Arterioscler Thromb Vasc Biol; 2004 Sep 23; 24(9):1720-6. PubMed ID: 15242858 [Abstract] [Full Text] [Related]
15. Cellular antioxidant effects of atorvastatin in vitro and in vivo. Wassmann S, Laufs U, Müller K, Konkol C, Ahlbory K, Bäumer AT, Linz W, Böhm M, Nickenig G. Arterioscler Thromb Vasc Biol; 2002 Feb 01; 22(2):300-5. PubMed ID: 11834532 [Abstract] [Full Text] [Related]
16. Simvastatin ameliorates angiotensin II-induced endothelial dysfunction through restoration of Rho-BH4-eNOS-NO pathway. Zhang Z, Wang M, Xue SJ, Liu DH, Tang YB. Cardiovasc Drugs Ther; 2012 Feb 01; 26(1):31-40. PubMed ID: 22083280 [Abstract] [Full Text] [Related]
17. Atorvastatin inhibits homocysteine-induced oxidative stress and apoptosis in endothelial progenitor cells involving Nox4 and p38MAPK. Bao XM, Wu CF, Lu GP. Atherosclerosis; 2010 May 01; 210(1):114-21. PubMed ID: 20018284 [Abstract] [Full Text] [Related]
18. The effect of high glucose on NO and O2- through endothelial GTPCH1 and NADPH oxidase. Ding QF, Hayashi T, Packiasamy AR, Miyazaki A, Fukatsu A, Shiraishi H, Nomura T, Iguchi A. Life Sci; 2004 Nov 12; 75(26):3185-94. PubMed ID: 15488897 [Abstract] [Full Text] [Related]
19. Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ. Wagner AH, Schwabe O, Hecker M. Br J Pharmacol; 2002 May 12; 136(1):143-9. PubMed ID: 11976279 [Abstract] [Full Text] [Related]
20. Beneficial effect of insulin in hyperhomocysteinemia and diabetes mellitus-induced vascular endothelium dysfunction: role of phosphoinositide dependent kinase and protein kinase B. Sharma S, Singh M, Sharma PL. Mol Cell Biochem; 2011 Feb 12; 348(1-2):21-32. PubMed ID: 21069435 [Abstract] [Full Text] [Related] Page: [Next] [New Search]